secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENvue Medical, Inc. (FEED)
CIK:        0001326706
Form:       8-K
Filed at:   2026-07-10T20:01:30+00:00
Accession:  0001493152-26-032830
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ENvue Medical receives Nasdaq delisting notice for bid price non-compliance
---------------------------------------------------------------------------

- Closing bid price below $1.00 for 30 consecutive business days (May 26–July 8, 2026).
- Ineligible for 180-day cure period due to reverse stock split (1-for-10) on Aug 12, 2025.
- Company will request a hearing before Nasdaq Panel to appeal the determination.
- No assurance that continued listing will be granted or compliance regained.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326706/000149315226032830/0001493152-26-032830-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326706/000149315226032830/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-032830

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer